PT Ikapharmindo Putramas Tbk (IDX:IKPM)

Indonesia flag Indonesia · Delayed Price · Currency is IDR
234.00
-18.00 (-7.14%)
Last updated: Mar 3, 2026, 11:56 AM WIB
Market Cap424.53B -5.3%
Revenue (ttm)379.27B -10.7%
Net Income-27.76B
EPS-16.48
Shares Out1.68B
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume204,300
Average Volume867,980
Open228.00
Previous Close252.00
Day's Range228.00 - 246.00
52-Week Range190.00 - 340.00
Beta0.89
RSI49.18
Earnings DateMar 26, 2026

About IDX:IKPM

PT Ikapharmindo Putramas Tbk engages in the research and development, manufacturing, and marketing of pharmaceutical products in Indonesia. It operates through three segments: Non Pharma, Pharma, and Contract Manufacturing. The company offers prescription medicines various areas, including neurology, psychiatry, dermatology, nephrology, gastroenterology, cardiology, pulmonology, antibiotics and generics, and nutraceuticals; and pharmaceuticals, vitamins, and over-the-counter products. It also provides hair and baby care products. PT Ikapharmind... [Read more]

Sector Healthcare
Founded 1978
Employees 952
Stock Exchange Indonesia Stock Exchange
Ticker Symbol IKPM
Full Company Profile

Financial Performance

In 2024, IDX:IKPM's revenue was 412.07 billion, a decrease of -6.59% compared to the previous year's 441.14 billion. Earnings were 5.01 billion, a decrease of -67.30%.

Financial Statements